
Contact us
About company
By targeting the CXCR4 pathway, we aim to restore healthy immunity in patients with a broad range of rare diseases.
US 955 massachusetts avenue
Unknown
Not verified company
By targeting the CXCR4 pathway, we aim to restore healthy immunity in patients with a broad range of rare diseases.